Peter McColgan

Peter McColgan is a Global Development Leader at Roche, specializing in the Huntington’s disease program. They previously served as a Clinical Director and Honorary Consultant Neurologist at the National Hospital for Neurology and Neurosurgery and held a Senior Research Fellow position at UCL's Huntington’s disease centre. With over six years of experience in phase 1-3 clinical trials, Peter completed their PhD in Clinical Neuroscience, focusing on brain networks in the premanifest stage of Huntington's disease. They have also undertaken post-doctoral training at the Max Planck Institute for Human Cognitive and Brain Sciences in Leipzig, Germany.